Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Factors associated with health care utilization in pediatric multiple sclerosis.

Marrie RA, O'Mahony J, Maxwell C, Ling V, Till C, Barlow-Krelina E, Yeh EA, Arnold DL, Bar-Or A, Banwell B; Canadian Pediatric Demyelinating Disease Network.

Mult Scler Relat Disord. 2019 Nov 6;38:101511. doi: 10.1016/j.msard.2019.101511. [Epub ahead of print]

PMID:
31722282
2.

Therapeutic plasma exchange in children with acute demyelination: Kids are not small adults!

Yeh EA, Rostásy K.

Neurology. 2019 Oct 23. pii: 10.1212/WNL.0000000000008540. doi: 10.1212/WNL.0000000000008540. [Epub ahead of print] No abstract available.

PMID:
31645465
3.

Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.

Waters P, Fadda G, Woodhall M, O'Mahony J, Brown RA, Castro DA, Longoni G, Irani SR, Sun B, Yeh EA, Marrie RA, Arnold DL, Banwell B, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

JAMA Neurol. 2019 Sep 23. doi: 10.1001/jamaneurol.2019.2940. [Epub ahead of print]

4.

Early neuroaxonal injury is seen in the acute phase of pediatric optic neuritis.

Wilbur C, Reginald YA, Longoni G, Grover SA, Wong AM, Mabbott DJ, Arnold DL, Marrie RA, Bar-Or A, Banwell B, Costello F, Yeh EA; Canadian Pediatric Demyelinating Disease Network.

Mult Scler Relat Disord. 2019 Sep 7;36:101387. doi: 10.1016/j.msard.2019.101387. [Epub ahead of print]

PMID:
31539739
5.

Rituximab in children with myelin oligodendrocyte glycoprotein antibody and relapsing neuroinflammatory disease.

Albassam F, Longoni G, Yea C, Wilbur C, Grover SA, Yeh EA.

Dev Med Child Neurol. 2019 Aug 30. doi: 10.1111/dmcn.14336. [Epub ahead of print]

PMID:
31468511
6.

Vaccination: Not a trigger for MS.

Yeh EA, Graves J.

Neurology. 2019 Aug 27;93(9):377-378. doi: 10.1212/WNL.0000000000008000. Epub 2019 Jul 30. No abstract available.

PMID:
31363059
7.

Demyelinating lesions and progressive MS: Location, location, location.

Yeh EA, Fox RJ.

Neurology. 2019 Aug 13;93(7):283-284. doi: 10.1212/WNL.0000000000007933. Epub 2019 Jul 9. No abstract available.

PMID:
31289147
8.

White matter plasticity and maturation in human cognition.

Bells S, Lefebvre J, Longoni G, Narayanan S, Arnold DL, Yeh EA, Mabbott DJ.

Glia. 2019 Nov;67(11):2020-2037. doi: 10.1002/glia.23661. Epub 2019 Jun 24. Review.

PMID:
31233643
9.

High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study.

Marrie RA, O'Mahony J, Maxwell CJ, Ling V, Yeh EA, Arnold DL, Bar-Or A, Banwell B; Canadian Pediatric Demyelinating Disease Network.

PLoS One. 2019 Jun 11;14(6):e0218215. doi: 10.1371/journal.pone.0218215. eCollection 2019.

10.

Improving Outcomes in Pediatric Multiple Sclerosis: Current and Emerging Treatments.

Wilbur C, Yeh EA.

Paediatr Drugs. 2019 Jun;21(3):137-152. doi: 10.1007/s40272-019-00338-6. Review.

PMID:
31155694
11.

Depressive symptoms, sleep patterns, and physical activity in adolescents with narcolepsy.

Parmar A, Yeh EA, Korczak DJ, Weiss SK, Lu Z, Zweerink A, Toulany A, Murray BJ, Narang I.

Sleep. 2019 Aug 1;42(8). pii: zsz111. doi: 10.1093/sleep/zsz111.

PMID:
31070768
12.

Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG.

Waubant E, Banwell B, Wassmer E, Sormani MP, Amato MP, Hintzen R, Krupp L, Rostásy K, Tenembaum S, Chitnis T; IPMSSG.

Neurology. 2019 May 28;92(22):e2538-e2549. doi: 10.1212/WNL.0000000000007572. Epub 2019 May 1. Erratum in: Neurology. 2019 Oct 1;93(14):647.

13.

An upfront immunomodulatory therapy protocol for pediatric opsoclonus-myoclonus syndrome.

Wilbur C, Yea C, Licht C, Irwin MS, Yeh EA.

Pediatr Blood Cancer. 2019 Aug;66(8):e27776. doi: 10.1002/pbc.27776. Epub 2019 Apr 29.

PMID:
31033188
14.

PANDAS/PANS in childhood: Controversies and evidence.

Wilbur C, Bitnun A, Kronenberg S, Laxer RM, Levy DM, Logan WJ, Shouldice M, Yeh EA.

Paediatr Child Health. 2019 May;24(2):85-91. doi: 10.1093/pch/pxy145. Epub 2018 Dec 9.

PMID:
30996598
15.

Treatment of rituximab-associated chronic CNS enterovirus using IVIg and fluoxetine.

Sham L, Bitnun A, Branson H, Hazrati LN, Dell SD, Yeung RSM, Johnstone J, Yeh EA.

Neurology. 2019 May 7;92(19):916-918. doi: 10.1212/WNL.0000000000007468. Epub 2019 Apr 3. No abstract available.

PMID:
30944242
16.

Benefits of Physical Activity for Depression and Fatigue in Multiple Sclerosis: A Longitudinal Analysis.

Stephens S, Shams S, Lee J, Grover SA, Longoni G, Berenbaum T, Finlayson M, Motl RW, Yeh EA.

J Pediatr. 2019 Jun;209:226-232.e2. doi: 10.1016/j.jpeds.2019.01.040. Epub 2019 Mar 14.

PMID:
30878208
17.

Evolution of regional brain atrophy in children with multiple sclerosis: Gray matters.

Yeh EA, Eshaghi A.

Neurology. 2019 Apr 9;92(15):694-695. doi: 10.1212/WNL.0000000000007254. Epub 2019 Mar 13. No abstract available.

PMID:
30867265
18.

Enhanced Recruitment During Executive Control Processing in Cognitively Preserved Patients With Pediatric-Onset MS.

Barlow-Krelina E, Turner GR, Akbar N, Banwell B, Lysenko M, Yeh EA, Narayanan S, Collins DL, Aubert-Broche B, Till C.

J Int Neuropsychol Soc. 2019 Apr;25(4):432-442. doi: 10.1017/S135561771800125X. Epub 2019 Feb 28.

PMID:
30813973
19.

Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis.

Mexhitaj I, Nyirenda MH, Li R, O'Mahony J, Rezk A, Rozenberg A, Moore CS, Johnson T, Sadovnick D, Collins DL, Arnold DL, Gran B, Yeh EA, Marrie RA, Banwell B, Bar-Or A.

Brain. 2019 Mar 1;142(3):617-632. doi: 10.1093/brain/awz017.

PMID:
30759186
20.

Live-cell based assays are the gold standard for anti-MOG-Ab testing.

Yeh EA, Nakashima I.

Neurology. 2019 Mar 12;92(11):501-502. doi: 10.1212/WNL.0000000000007077. Epub 2019 Feb 6. No abstract available.

PMID:
30728306
21.

A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis.

Fadda G, Brown RA, Magliozzi R, Aubert-Broche B, O'Mahony J, Shinohara RT, Banwell B, Marrie RA, Yeh EA, Collins DL, Arnold DL, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

Ann Neurol. 2019 Mar;85(3):340-351. doi: 10.1002/ana.25429. Epub 2019 Feb 20.

22.

Forecasting outcomes in anti-NMDAR encephalitis: Clearer prognostic markers needed.

Rüegg S, Yeh EA, Honnorat J.

Neurology. 2019 Jan 15;92(3):119-120. doi: 10.1212/WNL.0000000000006766. Epub 2018 Dec 21. No abstract available.

PMID:
30578369
23.

Acute flaccid myelitis.

Gill PJ, Bitnun A, Yeh EA.

CMAJ. 2018 Dec 3;190(48):E1418. doi: 10.1503/cmaj.181442. No abstract available.

PMID:
30510047
24.

Author Correction: Neuroimmune disorders of the central nervous system in children in the molecular era.

Wells E, Hacohen Y, Waldman A, Tillema JM, Soldatos A, Ances B, Benseler S, Bielekova B, Dale RC, Dalmau J, Gaillard W, Gorman M, Greenberg B, Hyslop A, Pardo CA, Tasker RC, Yeh EA, Bar-Or A, Pittock S, Vanderver A, Banwell B; attendees of the International Neuroimmune Meeting.

Nat Rev Neurol. 2018 Dec;14(12):749. doi: 10.1038/s41582-018-0077-9.

PMID:
30442924
25.

Acute Flaccid Myelitis in a 10-Year-Old Girl.

Ertl-Wagner B, Branson H, Shroff M, Bitnun A, Yeh EA.

Radiology. 2019 Jan;290(1):31. doi: 10.1148/radiol.2018182430. Epub 2018 Nov 6. No abstract available.

PMID:
30398439
26.

A Scoping Review of Modifiable Risk Factors in Pediatric Onset Multiple Sclerosis: Building for the Future.

Pétrin J, Fiander M, Doss PMIA, Yeh EA.

Children (Basel). 2018 Oct 26;5(11). pii: E146. doi: 10.3390/children5110146. Review.

27.

Incidence and prevalence of MS in children: A population-based study in Ontario, Canada.

Marrie RA, O'Mahony J, Maxwell C, Ling V, Yeh EA, Arnold DL, Bar-Or A, Banwell B; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2018 Oct 23;91(17):e1579-e1590. doi: 10.1212/WNL.0000000000006395. Epub 2018 Sep 26.

PMID:
30258022
28.

Physical activity and dentate gyrus volume in pediatric acquired demyelinating syndromes.

Longoni G, Brown RA, Aubert-Broche B, Grover SA, Branson HM, Fetco D, Bar-Or A, Marrie RA, Motl RW, Collins DL, Narayanan S, Arnold DL, Banwell B, Yeh EA.

Neurol Neuroimmunol Neuroinflamm. 2018 Sep 6;5(6):e499. doi: 10.1212/NXI.0000000000000499. eCollection 2018 Nov.

29.

Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review.

Mansour M, Liy Wong C, Zulian F, Li S, Morishita K, Yeh EA, Stewart K, Laxer RM, Pope E.

Pediatr Dermatol. 2018 Nov;35(6):761-768. doi: 10.1111/pde.13605. Epub 2018 Sep 6. Review.

PMID:
30187959
30.

MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.

Fadda G, Brown RA, Longoni G, Castro DA, O'Mahony J, Verhey LH, Branson HM, Waters P, Bar-Or A, Marrie RA, Yeh EA, Narayanan S, Arnold DL, Banwell B; Canadian Pediatric Demyelinating Disease Network.

Lancet Child Adolesc Health. 2018 Mar;2(3):191-204. doi: 10.1016/S2352-4642(18)30026-9. Epub 2018 Feb 1.

PMID:
30169254
31.

Pediatric-onset multiple sclerosis is associated with reduced parental health-related quality of life and family functioning.

O'Mahony J, Marrie RA, Laporte A, Bar-Or A, Yeh EA, Brown A, Dilenge ME, Banwell B.

Mult Scler. 2019 Oct;25(12):1661-1672. doi: 10.1177/1352458518796676. Epub 2018 Aug 30.

PMID:
30160208
32.

Radiologically isolated syndrome in children: Current knowledge and future directions.

Wilbur C, Yeh EA.

Mult Scler Relat Disord. 2018 Aug;24:79-84. doi: 10.1016/j.msard.2018.06.010. Epub 2018 Jun 21. Review.

PMID:
29966829
33.

Acute Flaccid Paralysis and Enteroviral Infections.

Bitnun A, Yeh EA.

Curr Infect Dis Rep. 2018 Jun 29;20(9):34. doi: 10.1007/s11908-018-0641-x. Review.

PMID:
29959591
34.

Lyme disease presenting with multiple cranial neuropathies on MRI.

Piché-Renaud PP, Branson H, Yeh EA, Morris SK.

IDCases. 2018 Apr 11;12:117-118. doi: 10.1016/j.idcr.2018.04.004. eCollection 2018.

35.

Neuroimmune disorders of the central nervous system in children in the molecular era.

Wells E, Hacohen Y, Waldman A, Tillema JM, Soldatos A, Ances B, Benseler S, Bielekova B, Dale RC, Dalmau J, Gaillard W, Gorman M, Greenberg B, Hyslop A, Pardo CA, Tasker RC, Yeh EA, Bar-Or A, Pittock S, Vanderver A, Banwell B; attendees of the International Neuroimmune Meeting.

Nat Rev Neurol. 2018 Jul;14(7):433-445. doi: 10.1038/s41582-018-0024-9. Review. Erratum in: Nat Rev Neurol. 2018 Dec;14(12):749.

PMID:
29925924
36.

Involvement of the Amygdala in Memory and Psychosocial Functioning in Pediatric-Onset Multiple Sclerosis.

Green R, Adler A, Banwell BL, Fabri TL, Yeh EA, Collins DL, Sled JG, Narayanan S, Till C.

Dev Neuropsychol. 2018;43(6):524-534. doi: 10.1080/87565641.2018.1485679. Epub 2018 Jun 18.

PMID:
29911891
37.

Adherence in Youth With Multiple Sclerosis: A Qualitative Assessment of Habit Formation, Barriers, and Facilitators.

Yeh EA, Chiang N, Darshan B, Nejati N, Grover SA, Schwartz CE, Slater R, Finlayson M; Pediatric MS Adherence Study Group.

Qual Health Res. 2019 Apr;29(5):645-657. doi: 10.1177/1049732318779039. Epub 2018 Jun 17.

PMID:
29911511
38.

Detection and clinical correlation of leukocortical lesions in pediatric-onset multiple sclerosis on multi-contrast MRI.

Maranzano J, Till C, Assemlal HE, Fonov V, Brown R, Araujo D, O'Mahony J, Yeh EA, Bar-Or A, Marrie RA, Collins L, Banwell B, Arnold DL, Narayanan S.

Mult Scler. 2019 Jun;25(7):980-986. doi: 10.1177/1352458518779952. Epub 2018 Jun 1.

PMID:
29852831
39.

Evaluation of an Ophthalmoscopy Simulator to Teach Funduscopy Skills to Pediatric Residents.

Kouzmitcheva E, Grover SA, Berenbaum T, Ali A, Atkinson A, Yeh EA.

Can J Neurol Sci. 2018 May;45(3):320-324. doi: 10.1017/cjn.2017.291. Epub 2018 Feb 19.

PMID:
29455676
40.

Correction to: Impact of an electronic monitoring device and behavioural feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.

Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE; Pediatric MS Adherence Study Group.

Qual Life Res. 2018 Apr;27(4):1117. doi: 10.1007/s11136-017-1773-4.

41.

Specific myelopathy diagnoses using advancing diagnostics: Idiopathic no more.

Yeh EA, Hintzen RQ.

Neurology. 2018 Jan 9;90(2):51-52. doi: 10.1212/WNL.0000000000004812. Epub 2017 Dec 15. No abstract available.

PMID:
29247075
42.

Radiologically isolated syndrome in children: Can we predict future events?

Yeh EA.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 23;4(6):e411. doi: 10.1212/NXI.0000000000000411. eCollection 2017 Nov. No abstract available.

43.

Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas.

Yeh EA, Greenberg J, Abla O, Longoni G, Diamond E, Hermiston M, Tran B, Rodriguez-Galindo C, Allen CE, McClain KL; North American Consortium for Histiocytosis.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26784. Epub 2017 Sep 25. Review.

PMID:
28944988
44.

A feasibility study of working memory training for individuals with paediatric-onset multiple sclerosis.

Till C, Kuni B, De Somma E, Yeh EA, Banwell B.

Neuropsychol Rehabil. 2019 Sep;29(8):1177-1192. doi: 10.1080/09602011.2017.1372786. Epub 2017 Sep 18.

PMID:
28920511
45.

Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.

Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE; Pediatric MS Adherence Study Group.

Qual Life Res. 2017 Sep;26(9):2333-2349. doi: 10.1007/s11136-017-1571-z. Epub 2017 Apr 9. Erratum in: Qual Life Res. 2017 Dec 23;:.

46.

Interferon-Stimulated Gene Expression as a Preferred Biomarker for Disease Activity in Aicardi-Goutières Syndrome.

Wang BX, Grover SA, Kannu P, Yoon G, Laxer RM, Yeh EA, Fish EN.

J Interferon Cytokine Res. 2017 Apr;37(4):147-152. doi: 10.1089/jir.2016.0117. Epub 2017 Feb 17.

PMID:
28387595
47.

Monophasic demyelination reduces brain growth in children.

Aubert-Broche B, Weier K, Longoni G, Fonov VS, Bar-Or A, Marrie RA, Yeh EA, Narayanan S, Arnold DL, Verhey LH, Banwell B, Collins DL; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2017 May 2;88(18):1744-1750. doi: 10.1212/WNL.0000000000003884. Epub 2017 Apr 5.

48.

White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.

Longoni G, Brown RA, MomayyezSiahkal P, Elliott C, Narayanan S, Bar-Or A, Marrie RA, Yeh EA, Filippi M, Banwell B, Arnold DL; Canadian Pediatric Demyelinating Disease Network.

Brain. 2017 May 1;140(5):1300-1315. doi: 10.1093/brain/awx041.

PMID:
28334875
49.

Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis.

Schwartz CE, Grover SA, Powell VE, Noguera A, Mah JK, Mar S, Mednick L, Banwell BL, Alper G, Rensel M, Gorman M, Waldman A, Schreiner T, Waubant E, Yeh EA.

Mult Scler. 2018 Feb;24(2):175-185. doi: 10.1177/1352458517695469. Epub 2017 Feb 1.

PMID:
28273780
50.

Longitudinal Outcomes in the 2014 Acute Flaccid Paralysis Cluster in Canada.

Yea C, Bitnun A, Robinson J, Mineyko A, Barton M, Mah JK, Vajsar J, Richardson S, Licht C, Brophy J, Crone M, Desai S, Hukin J, Jones K, Muir K, Pernica JM, Pless R, Pohl D, Rafay MF, Selby K, Venkateswaran S, Bernard G, Yeh EA.

J Child Neurol. 2017 Mar;32(3):301-307. doi: 10.1177/0883073816680770. Epub 2016 Dec 20.

PMID:
28193112

Supplemental Content

Loading ...
Support Center